Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares OutstandingShares Outstanding
Ratios

Medifast (MED) Other Gross PP&E Adjustments (2016 - 2025)

Medifast's Other Gross PP&E Adjustments history spans 16 years, with the latest figure at $89.5 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 8.3% year-over-year to $89.5 million; the TTM value through Dec 2025 reached $89.5 million, up 8.3%, while the annual FY2025 figure was $89.5 million, 8.3% up from the prior year.
  • Other Gross PP&E Adjustments reached $89.5 million in Q4 2025 per MED's latest filing, up from -$8.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $89.5 million in Q4 2025 to a low of -$22.9 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $8.4 million, with a median of -$12.9 million recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: surged 48.03% in 2021, then crashed 138.41% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $64.0 million in 2021, then rose by 19.29% to $76.3 million in 2022, then increased by 6.62% to $81.3 million in 2023, then increased by 1.62% to $82.7 million in 2024, then grew by 8.3% to $89.5 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Other Gross PP&E Adjustments are $89.5 million (Q4 2025), -$8.4 million (Q3 2025), and -$8.9 million (Q2 2025).